The incidence of anaphylactoid reactions to anaesthetic drugs is of the order of 1 :20,000 anaesthetics. I About 10% of such reactions in Australia are due to thiopentone 2 and Boileau et al. (1985) found 258 cases of thiopentone anaphylaxis in the literature up to 1985,3 although the nature of the study was such that SQme reactions were omitted and some reactions included twice. Two prospective studies 4 ,5. have suggested an incidence of anaphylactoid reactions to thiopentone of 1 :22773 cases and 1 :28827 cases, although in the second series two cases had relaxants administered at the same time and there was no attempt to distinguish the cause.
We describe the investigation and clinical manifestations of three anaphylactic reactions to thiopentone which occurred over a fourmonth period in a single hospital and involved a single anaesthetist.
Case 1
A 38-year-old man with no history of allergy or atopy and ten uneventful previous anaesthetics was anaesthetised for a back manipulation by an orthopaedic surgeon. Thiopentone 400 mg and epidural solumedrol were the only agents administered on April 2 7, 1988 . At the end of the procedure (5 minutes) he began to cough and was placed in the left lateral position. Two minutes later when he was wide awake he began to sweat profusely and complained of severe epigastric pain, chest pain radiating down the right arm and nausea. His peripheral pulses became unpalpable. He was given 500 ml of Ringers lactate rapidly which brought his BP to 40 mmHg systolic, and his sweating ceased. ECG showed sinus tachycardia (l10/minute) and ST elevation. He was given 10 mg of metaraminol in divided doses which brought his BP to normal. At about this time he began to vomit coffee-ground material (which tested positive for blood) and developed an erythematous rash. He was transferred to Auburn District Hospital and had no further chest pain or hypotension, but nausea and epigastric discomfort persisted for three hours. Stress testing, cardiac enzymes and serial ECGs showed no abnormality.
Case 2
A 39-year-old woman was anaesthetised with thiopentone 300 mg for a back manipulation by an orthopaedic surgeon on August 10, 1988 . She had no history of allergy or atopy and had received at least ten previous anaesthetics eneventfully. About 15 minutes after induction and 12 minutes after awakening, when she was being discharged from the recovery ward, she became cyanosed, commenced vomiting and her peripheral pulses became impalpable. Over the next hour she received repeated intermittent doses of adrenaline and two litres of SPPS to maintain blood pressure and continued vomiting blood stained material for 3-4 hours. She developed oedema of the lips and periorbital oedema which persisted for eight hours.
Case 3
A 42-year-old obese woman was anaesthetised with 300 mg of thiopentone for a sympathetic block on August 26, 1988. She had a past history of glucose-6-phosphatase deficiency, and of one episode of urticaria on exposure to beans growing in a field. After induction, a tourniquet was inflated upon her right upper arm and 10 mg of guanethidine in 20 ml and 0.5% lignocaine was injected by another clinician. She awoke and after 10 minutes her blood pressure became unrecordable and she complained of chest and abdominal pain. ECG showed sinus tachycardia and ST elevation. She was given 1000 ml of Ringers lactate rapidly and 8 cc of adrenaline 1: 1 0,000 was slowly injected intravenously. Her pulses became palpable after 10 minutes but her blood pressure was still unrecordable. Within five minutes her blood pressure was 50-60 mmHg systolic, her pulse slowed and she developed ventricular ectopics. Adrenaline was ceased and she was given 50 mg of xylocaine and 10 mg of metaraminol. Her ECG reverted to normal and her blood pressure rose to 80 mmHg systolic. The abdominal pain however, persisted for three hours. Cardiac enzymes were not elevated. She had had eight previous anaesthetics, and had received thiopentone uneventfully twice in the same month. The tourniquet was not released until the blood pressure was stable. Post reaction stress testing showed no cardiac abnormality.
METHODS

In vivo testing
Intradermal testing 6 and prick testing 7 were carried out one month after the reactions.
Detection of thiopentone -specific IgE antibodies
These were detected using the radioimmunoassay and inhibition procedures already described. 8 ,9
Control sera
Sera from cord blood was obtained from the Department of Obstetrics, Royal North Shore Hospital. Sera from non-allergic, healthy adults were collected from hospital staff members. Sera from adults allergic to house dust mites and/or grass pollens were obtained after clinical diagnosis had been confirmed by the detection of allergenspecific IgE antibodies in the radioallergo- sorbent test (RAST). These sera showed radio-active uptakes of 1251-anti-human-IgE of 10-45%.
RESULTS
The results of intradermal 6 and prick testing 7 are shown in Table 1 . Tests were positive in Cases 1 and 3 and negative in Case 2. However, Case 2, seventy-five minutes after testing was completed, developed nausea and vomiting, profuse sweating and oedema of the eyelids and lips and was hospitalised but improved without treatment. Table 2 shows the results of radioimmunoassay testing and inhibition studies for thiopentone-specific IgE antibodies. These were detected using a radioimmunoassay which has been previously described using thiopentone coupled to a Sepharose solid support. The sera from all three subjects gave clear positive reactions with the thiopentone-solid support. Radioactive uptakes of 1251-anti-IgE with these sera were from 3.3 to 14.4 times the uptakes recorded with control sera, which consisted of cord sera, sera from non-allergic subjects and sera from subjects allergic to house dust mites and/or pollens. On the basis of our own extensive previous experience and the experience of others, of measuring allergenspecific IgE antibodies in the RAST, a radioactive uptake of I 251-anti-human IgE of at least 2.5-3 times the control uptakes was regarded as a positive reaction. 8 ,lo,11 The specificity of the IgE antibody reaction with thiopentone-Sepharose was confirmed by inhibition studies with the free drug. Significant inhibition of IgE-binding was obtained when thiopentone was preincubated with each of the three sera (Table   2) . DISCUSSION The occurrence of the three anaphylactic reactions to thiopentone occurring in a single hospital in the practice of a single anaesthetist is an unusual and unlikely event. There is unequivocal evidence in these three cases that the reactions were IgE-mediated anaphylactic reactions to thiopentone sodium. The drug was the sole anaesthetic agent, although depomedrol was given to Case 1, and lignocaine/guanethidine in Case 3. Intradermal and prick tests were positive in two cases and provoked a reaction in the other case, and significant levels of thiopentonereactive IgE antibodies were found in the sera of all three patients. Although tests for specific IgE antibodies to thiopentone may show false positives, particularly in patients with high IgE levels l2 and in patients who have antibodies to muscle relaxants,13 the employment of inhibition studies enables false positives to be distinguished. 8 ,9,13 Also, although the degree of inhibition obtained with thiopentone tends to be lower than we find in other drug inhibition studies (for example with muscle relaxants, morphine, trimethoprim and sulfamethoxazole), values of approximately 20% inhibition or more with 5/l moles of thiopentone have been shown to correlate with clinical symptoms of anaphylaxis to the drug. 9 ,13 The occurrence of a series of reactions to a single anaesthetic drug had previously occurred in this country, and may lead to withdrawal of the drug transiently, on the suspicion that the disorder is batch-related. The likelihood of three reactions to thiopentone occurring in the practice of a single anaesthetist over four months is of the order of 1: 1 0. 12 Such an occurrence may also lead to questions regarding the competence of the doctor concerned, The investigations performed in these patients show clearly that the reactions were truly immunological and apparently not related to an unusual or different batch of drug, and their occurrence was unrelated to the technique or skill of the anaesthetist.
The reactions followed unusual patterns in which it was initially considered that primary cardiac causes were likely. Such presentation has, in patients we have described in the past, led to misdiagnosis and repeated anaphylaxis. 8 All three patients had gastrointestinal symptoms which are only observed in about 10% of patients with anaphylaxis during anaesthesia. 14 However, these patients differ from the majority in our series in that they suffered anaphylaxis related to induction agents but were awake during the reaction. It may be that involvement of the gastrointestinal system is greater than previously realised, but masked by continuation of anaesthesia during resuscitation.
All patients had a past history of multiple anaesthetics in which thiopentone was used. Clark and Cockburn l5 noted this in their study of thiopentone anaphylaxis, and this is in contrast to anaphylaxis to muscle relaxants where reactions usually occur on first exposure. 16 This does not mean, however, that multiple thiopentone anaesthetics are a reasonable predictor of anaphylaxis as many patients undergoing uneventful exposure to thiopentone will have such a history.
The lack of a skin test response to intradermal testing (and prick testing) in Case 2 is disturbing. A similar case has been described with vecuronium. 17 While the systemic reaction that occurred confirmed the diagnosis, it is obviously an undesirable way to achieve such an end. Intradermal testing has been shown in many independent investigations to be the most useful method of determining the drug responsible for an anaesthetic anaphylactoid reaction. The response in this case underscores the axiom that if a patient undergoes a life-threatening reaction clinically resembling anaphylaxis during anaesthesia, and a properly conducted intradermal test is performed, it is likely that one of the drugs used in the anaesthetic will show a positive test. If this occurs, it is likley that that drug is responsible for the reaction and that other drugs showing positive skin tests will produce a similar reaction. Further, under these circumstances, drugs which show negative tests are probably safe. When intradermal tests are negative it is difficult to categorically state which drugs are subsequently safe and it is best to avoid all drugs used previously. No patient in our series (of over three hundred patients) who has shown negative reactions to all intradermal tests has had a severe reaction during subsequent anaesthesia. The result of intradermal testing in Case 2 also must raise questions as to the safety of the procedure. Case 2 suffered the second systemic anaphylactic reaction we have seen in over fourteen years and five hundred skin tests: the other reaction was immediate. It may be that patients who have had a life-threatening reaction require a period of observation after negative skin tests. pressure trace was obtained from the distal lumen. The tricuspid valve had not been crossed by 35 cm (measured from the external end of the sheath), but because of the possible extended venous course around the goitre it was decided to advance a further 5-7 cm. At 42 cm just as the balloon was being deflated. The catheter crossed the tricuspid valve the balloon was fully inflated again and the catheter advanced with the pulmonary artery being entered at about 52 cm. The catheter was further advanced to a 'wedged' position at 63 cm. The pressure trace from the proximal port was noted to be of right ventricular pressure and it was assumed that the catheter had looped in the right ventricle. The balloon was deflated and withdrawal of the catheter was commenced in 5 cm steps with re-inflations of the balloon after each to check if a 'wedge pressure' was still obtained. At the
